Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal

Samsung Biologics acquires PolyPeptide Group for 2.7 trillion won ($1.8 billion)

By CNBC · CNBC

Samsung Biologics acquires PolyPeptide Group for 2.7 trillion won ($1.8 billion)